Back to News
Market Impact: 0.4
Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up
Source: 247wallst.com
Healthcare & BiotechProduct LaunchesCompany Fundamentals
Novavax shares rose 17% in afternoon trading after Sanofi moved Nuvaxovid into the fall COVID-19 vaccination season. The article says Novavax’s gain substantially outpaced the rest of biotech.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
strongly positive
Sentiment Score
0.55
Ticker Sentiment
NVAX0.65
SNY0.30
More News
- Why is Novavax stock surging today?
- Press Release : Availability of the aide-mémoire for Q3 2026 results
- Samsung, SK Hynix shares drop as Q3 earnings loom
- CH Robinson to Buy RXO for $5.8B in Bet on AI Model
- BPCE acquires 7% stake in Spain’s Banco Sabadell
- OKX debuts a platform that turns 50 currencies into digital dollars, betting emerging market investors want stablecoins